| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |